- Report
- January 2024
- 181 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Clinical Trials
- February 2024
- 60 Pages
Global
From €1199EUR$1,250USD£1,033GBP
- Report
- December 2023
- 140 Pages
Global
From €4270EUR$4,450USD£3,678GBP
- Report
- October 2023
Middle East, Africa
From €1439EUR$1,500USD£1,240GBP
- Report
- April 2023
- 249 Pages
Global
From €4030EUR$4,200USD£3,471GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,264GBP
- Clinical Trials
- July 2021
- 256 Pages
Global
From €2399EUR$2,500USD£2,066GBP
- Clinical Trials
- January 2021
- 244 Pages
Global
From €2399EUR$2,500USD£2,066GBP
- Report
- October 2023
- 89 Pages
Global
From €3500EUR$3,908USD£3,120GBP
- Report
- May 2022
- 42 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Book
- November 2013
- 982 Pages
- Book
- August 2022
- 448 Pages
- Book
- April 2024
- 1216 Pages
- Book
- July 2020
- 416 Pages
- Book
- March 2019
- 648 Pages
- Book
- December 2018
- 1136 Pages
- Book
- October 2018
- 144 Pages
- Book
- June 2018
- 816 Pages
- Book
- October 2010
- 760 Pages
- Book
- December 2023
- 496 Pages
Pre-eclampsia is a serious medical condition that affects pregnant women, typically during the second half of their pregnancy. It is characterized by high blood pressure, protein in the urine, and swelling of the hands and feet. If left untreated, pre-eclampsia can lead to serious complications for both the mother and the baby. Women's health organizations recommend regular check-ups and monitoring of blood pressure during pregnancy to help detect pre-eclampsia early.
There are a number of companies in the pre-eclampsia market that provide products and services to help diagnose and manage the condition. These include diagnostic tests, monitoring devices, and treatments. Companies such as Abbott, Roche, and Siemens Healthineers provide diagnostic tests, while Philips and Medtronic offer monitoring devices. Other companies such as Novartis and Pfizer provide treatments for pre-eclampsia. Show Less Read more